Jorge Moscat

Active 1987–2025

117
Papers
22,256
Citations
87
h-index
114
i10-index

Citations

Citations per year for Jorge Moscat1988: 13 citations1989: 19 citations1990: 20 citations1991: 14 citations1992: 22 citations1993: 36 citations1994: 66 citations1995: 93 citations1996: 125 citations1997: 151 citations1998: 157 citations1999: 286 citations2000: 235 citations2001: 260 citations2002: 241 citations2003: 250 citations2004: 203 citations2005: 206 citations2006: 167 citations2007: 150 citations2008: 179 citations2009: 224 citations2010: 184 citations2011: 206 citations2012: 218 citations2013: 203 citations2014: 212 citations2015: 147 citations2016: 233 citations2017: 237 citations2018: 305 citations2019: 724 citations2020: 863 citations2021: 919 citations2022: 641 citations2023: 538 citations2024: 718 citations2025: 398 citations2026: 10 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,672 citing papers, 28.1% of this breakdownChina: 1,927 citing papers, 20.3% of this breakdownUnited Kingdom: 502 citing papers, 5.3% of this breakdownGermany: 431 citing papers, 4.5% of this breakdownJapan: 402 citing papers, 4.2% of this breakdownSpain: 286 citing papers, 3% of this breakdownItaly: 283 citing papers, 3% of this breakdownFrance: 270 citing papers, 2.9% of this breakdownCanada: 256 citing papers, 2.7% of this breakdownSouth Korea: 222 citing papers, 2.3% of this breakdownAustralia: 165 citing papers, 1.7% of this breakdownIndia: 138 citing papers, 1.5% of this breakdown
0%28.1%Other 20.5%

Fields

  • Biochemistry, Genetics and Molecular Biology47.5%
  • Medicine40.9%
  • Immunology and Microbiology5.2%
  • Neuroscience3.6%
  • Agricultural and Biological Sciences0.6%
  • Engineering0.6%
  • Other1.6%

Topics

  • Autophagy in Disease and Therapy7.4%
  • Protein Kinase Regulation and GTPase Signaling2.6%
  • NF-κB Signaling Pathways2.4%
  • Cancer, Hypoxia, and Metabolism2.3%
  • Endoplasmic Reticulum Stress and Disease2.2%
  • Ubiquitin and proteasome pathways1.9%
  • Other81.2%

Coauthors

All papers

Open in search
  1. NF-κB Restricts Inflammasome Activation via Elimination of Damaged Mitochondria

    Authors: , , , , , , , , , , , , , , , , , - Cell 2016 cited by 1,167

  2. Fructose stimulated de novo lipogenesis is promoted by inflammation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Metabolism 2020 cited by 320

  3. p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells

    Authors: , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2016 cited by 458

  4. Celastrol-Induced Nur77 Interaction with TRAF2 Alleviates Inflammation by Promoting Mitochondrial Ubiquitination and Autophagy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Molecular Cell 2017 cited by 314

  5. Cancer cells escape autophagy inhibition via NRF2-induced macropinocytosis

    Authors: , , , , , , , , , , , , , , , , , , , - Cancer Cell 2021 cited by 219

  6. p62 at the Crossroads of Autophagy, Apoptosis, and Cancer

    Authors: , - Cell 2009 cited by 1,079

  7. TRIM21 Ubiquitylates SQSTM1/p62 and Suppresses Protein Sequestration to Regulate Redox Homeostasis

    Authors: , , , , , , , , , , , , , , , - Molecular Cell 2016 cited by 258

  8. Metabolism shapes the tumor microenvironment

    Authors: , , - Current Opinion in Cell Biology 2017 cited by 301

  9. Increased Serine and One-Carbon Pathway Metabolism by PKCλ/ι Deficiency Promotes Neuroendocrine Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , - Cancer Cell 2019 cited by 182

  10. THBS1-producing tumor-infiltrating monocyte-like cells contribute to immunosuppression and metastasis in colorectal cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kenji Kawada, Masakazu Yashiro, Kiyoshi Maeda, Yasuyuki Saito, Takashi Matozaki, Akihisa Fukuda, Kenji Kabashima, Kazutaka Obama, Seishi Ogawa, Nader Sheibani, María T. Diaz‐Meco, Jorge Moscat, Hiroshi Seno - Nature Communications 2023 cited by 101

  11. p62 in Cancer: Signaling Adaptor Beyond Autophagy

    Authors: , , - Cell 2016 cited by 396

  12. The lactate-NAD+ axis activates cancer-associated fibroblasts by downregulating p62

    Authors: , , , , , , , , , , , , , - Cell Reports 2022 cited by 69

  13. PKCλ/ι Loss Induces Autophagy, Oxidative Phosphorylation, and NRF2 to Promote Liver Cancer Progression

    Authors: , , , , , , , , , , , , , , , , , , - Cancer Cell 2020 cited by 154

  14. Stromal SOX2 Upregulation Promotes Tumorigenesis through the Generation of a SFRP1/2-Expressing Cancer-Associated Fibroblast Population

    Authors: , , , , , , , , , , , , , , , - Developmental Cell 2020 cited by 128

  15. ATF4-Induced Metabolic Reprograming Is a Synthetic Vulnerability of the p62-Deficient Tumor Stroma

    Authors: , , , , , , , , , - Cell Metabolism 2017 cited by 113

  16. p62 Is a Key Regulator of Nutrient Sensing in the mTORC1 Pathway

    Authors: , , , , , , , , - Molecular Cell 2011 cited by 496

  17. Hyaluronan driven by epithelial aPKC deficiency remodels the microenvironment and creates a vulnerability in mesenchymal colorectal cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2022 cited by 57

  18. The complexity of the serine glycine one-carbon pathway in cancer

    Authors: , , - The Journal of Cell Biology 2019 cited by 118

  19. p62/SQSTM1 by Binding to Vitamin D Receptor Inhibits Hepatic Stellate Cell Activity, Fibrosis, and Liver Cancer

    Authors: , , , , , , , , , , - Cancer Cell 2016 cited by 249

  20. Metabolic Reprogramming of Stromal Fibroblasts through p62-mTORC1 Signaling Promotes Inflammation and Tumorigenesis

    Authors: , , , , , , , , , , - Cancer Cell 2014 cited by 312

  21. K63 Polyubiquitination and Activation of mTOR by the p62-TRAF6 Complex in Nutrient-Activated Cells

    Authors: , , , , , - Molecular Cell 2013 cited by 259

  22. Control of Nutrient Stress-Induced Metabolic Reprogramming by PKCζ in Tumorigenesis

    Authors: , , , , , , , , , , , , , , , , , - Cell 2013 cited by 211

  23. NRF2 activates growth factor genes and downstream AKT signaling to induce mouse and human hepatomegaly

    Authors: , , , , , , , , , , , , , - Journal of Hepatology 2020 cited by 107

  24. The Signaling Adaptor p62 Is an Important NF-κB Mediator in Tumorigenesis

    Authors: , , , , , , - Cancer Cell 2008 cited by 542